AG
FOLD

Algert Global’s Amicus Therapeutics FOLD Stock Holding History

Algert Global’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-537,433
Closed -$4.24M – 1205
2025
Q3 		$4.24M Sell
537,433
-816,065
-60% -$5.81M 0.07% 454
2025
Q2 		$7.76M Buy
1,353,498
+533,472
+65% +$3.44M 0.16% 195
2025
Q1 		$6.69M Buy
820,026
+394,943
+93% +$3.65M 0.17% 188
2024
Q4 		$4M Buy
425,083
+165,923
+64% +$1.72M 0.09% 354
2024
Q3 		$2.77M Buy
259,160
+170,575
+193% +$1.86M 0.07% 449
2024
Q2 		$879K Buy
+88,585
New +$909K 0.03% 717
2024
Q1 		– Sell
-184,540
Closed -$2.62M – 1139
2023
Q4 		$2.62M Buy
+184,540
New +$2.1M 0.11% 326
2023
Q2 		– Sell
-330,425
Closed -$3.66M – 1139
2023
Q1 		$3.66M Buy
330,425
+52,073
+19% +$642K 0.17% 170
2022
Q4 		$3.4M Buy
278,352
+62,440
+29% +$703K 0.19% 148
2022
Q3 		$2.25M Buy
215,912
+164,364
+319% +$1.83M 0.14% 237
2022
Q2 		$554K Sell
51,548
-103,251
-67% -$850K 0.04% 722
2022
Q1 		$1.47M Buy
154,799
+108,673
+236% +$1.02M 0.1% 358
2021
Q4 		$533K Buy
46,126
+6,331
+16% +$70.6K 0.07% 515
2021
Q3 		$380K Buy
39,795
+20,541
+107% +$210K 0.05% 659
2021
Q2 		$186K Sell
19,254
-27,874
-59% -$272K 0.06% 362
2021
Q1 		$466K Sell
47,128
-11,340
-19% -$176K 0.15% 216
2020
Q4 		$1.35M Buy
58,468
+26,940
+85% +$551K 0.39% 91
2020
Q3 		$445K Sell
31,528
-45,550
-59% -$664K 0.14% 209
2020
Q2 		$1.16M Sell
77,078
-21,597
-22% -$263K 0.39% 83
2020
Q1 		$912K Buy
+98,675
New +$938K 0.38% 87

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Algert Global's FOLD Position: Q4 2025 in Review

Algert Global sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 537,433 shares — an estimated $4.24M sold.

Algert Global first reported a position in FOLD in Q1 2020 and held it in 20 quarters. The position peaked at $7.76M in Q2 2025. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Algert Global reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 537,433 Amicus Therapeutics shares in Q4 2025, an estimated $4.24M.
  • Algert Global first reported a position in Amicus Therapeutics in Q1 2020 and held it in 20 quarters.
  • Algert Global's Amicus Therapeutics position peaked at $7.76M in Q2 2025.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.